These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Jick S; Kaye JA; Li L; Jick H Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users. Bodner K; Bodner-Adler B; Grünberger W Arch Gynecol Obstet; 2011 Mar; 283(3):525-30. PubMed ID: 20111970 [TBL] [Abstract][Full Text] [Related]
12. Less estrogen in new oral contraceptive. Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126 [No Abstract] [Full Text] [Related]
13. Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism. Jick SS; Hagberg KW; Hernandez RK; Kaye JA Contraception; 2010 Jan; 81(1):16-21. PubMed ID: 20004268 [TBL] [Abstract][Full Text] [Related]
14. A clinical study of transdermal contraceptive patch in Thai adolescence women. Piyasirisilp R; Taneepanichskul S J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975 [TBL] [Abstract][Full Text] [Related]
15. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Brenner P Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246 [No Abstract] [Full Text] [Related]
16. Advances in hormonal contraception. Gupta N Adolesc Med Clin; 2006 Oct; 17(3):653-71; abstract xi. PubMed ID: 17030284 [TBL] [Abstract][Full Text] [Related]
17. The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra). Zieman M Fertil Steril; 2002 Feb; 77(2 Suppl 2):S1-2. PubMed ID: 11849629 [No Abstract] [Full Text] [Related]
18. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Jick SS; Kaye JA; Russmann S; Jick H Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560 [TBL] [Abstract][Full Text] [Related]